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Probe(s) - Courtesy Mariano Rocchi. 
DNA/RNA 
Description 
The EPHA7 gene maps on chromosome 6q16.1 
spanning 178,134 bp. it contains 17 exons, the 
orientation of the gene is complement. 
Transcription 
rTanscript of 5,229 bp. 
Protein 
Description 
EPHA7 encodes 998 amino acids, theoretical pI is 5.58, 
theoretical molecular weight is 112 KDa, tyrosine 
kinase, catalytic domain, sterile alpha motif, 2 
fibronectin type 3 domains, ephrin receptor ligand 
binding domain and tumor necrosis factor receptor 
domain. 
Expression 
In brain, skeletal muscle, lung, kidney, liver, 
colorectum and nerve system. 
Localisation 
Located in the membrane. 
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Function 
ATP Binding, ephrin receptor activity, nucleotide 
binding, protein binding, receptor activity, transferase 
activity. 
Homology 
Homo sapiens: EPHA5 isoform b [NP_872272] (64%), 
EPHA5 isoform a [NP_004430] (63%), EPHA4 
[NP_004429] (63%), EPHA3 [AAG43576] (63%). 
Implicated in 
Colorectal cancer 
Note: A significant reduction of EphA7 expression in 
human colorectal cancers was shown using 
semiquantitative reverse transcription-polymerase 
chain reaction analysis in 59 colorectal cancer tissue , 
compared to corresponding normal mucosas (P=0.008), 
and five colon cancer cell lines. To investigate th 
mechanism of EphA7 downregulation in colorectal 
cancer, we examined the methylation status of the 
5'CpG island around the translation start site in five 
colon cancer cell lines using restriction enzymes, 
methylation-specific PCR, and bisulfite sequencing a d
found evidence of aberrant methylation. The expression 
of EphA7 in colon cancer cell lines was restored after 
treatment with 5-aza-2'-deoxycytidine. Analysis of 
methylation status in totally 75 tumors compared to 
clinicopathological parameters revealed that 
hypermethylation of colorectal cancers was more 
frequent in male than in female, and in moderately 
differentiated than in well-differentiated 
adenocarcinomas. There was a tendency that 
hypermethylation in rectal cancers was more frequent 
than in colon cancers. Hypermethylation was also 
observed in colorectal adenomas. This is the first report 
describing the downregulation of an Eph family gene in  
a solid tumor via aberrant 5'CpG island methylation. It 
provides the evidence that EphA7 gene is involved in 
human colorectal carcinogenesis. 
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